WU
26
2
O
26
16
ADI
54
4
PBI
30
-8
HES
49
2
ROP
44
6
NDAQ
46
2
L
54
5
CMCSA
49
3
ABBV
40
5
IRM
33
5
AON
25
4
A
43
2
EA
41
3
EBAY
42
2
JNJ
30
4
CVS
27
2
SYF
78
7
ILMN
31
4
HSIC
42
2
WU
26
2
O
26
16
ADI
54
4
PBI
30
-8
HES
49
2
ROP
44
6
NDAQ
46
2
L
54
5
CMCSA
49
3
ABBV
40
5
IRM
33
5
AON
25
4
A
43
2
EA
41
3
EBAY
42
2
JNJ
30
4
CVS
27
2
SYF
78
7
ILMN
31
4
HSIC
42
2
Financhill
Back

Protara Therapeutics Vs. Nukkleus Industry Stock Comparison

Buy
55

TARA
Protara Therapeutics

Last Price:
$5.37
Seasonality Move:
26.72%
Sell
46

NUKK
Nukkleus

Last Price:
$40.15
Seasonality Move:
-21.57%
Buy
55
Protara Therapeutics (TARA) is a Buy

Is Protara Therapeutics a Buy, Sell or Hold?

  • The current Protara Therapeutics [TARA] share price is $5.37. The Score for TARA is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • TARA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

  • The current Nukkleus [NUKK] share price is $40.00. The Score for NUKK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TARA Stock Price Chart

What is Protara Therapeutics's stock price today?

  • The Protara Therapeutics share price today is $5.37
    The current trend is moderately bullish and TARA is experiencing buying pressure, which is a positive indicator for future bullish movement.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

  • The Nukkleus share price today is $40.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUKK is experiencing slight selling pressure.

TARA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.76 Buy
Relative Strength Index (14 RSI): 62.47 Buy
Chaikin Money Flow: 796791 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.54 - 5.84) Buy
Bollinger Bands (100): (1.3 - 3.84) Buy

NUKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.69 Buy
Relative Strength Index (14 RSI): 77.28 Buy
Chaikin Money Flow: -1366926 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (-7.5 - 22.6) Buy
Bollinger Bands (100): (-4.22 - 11.5) Buy

TARA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.67 Sell
20-day SMA: 4.65 Buy
50-day SMA: 3.21 Buy
200-day SMA: 2.75 Buy
8-day EMA: 5.42 Sell
20-day EMA: 4.8 Buy
50-day EMA: 3.69 Buy
200-day EMA: 2.78 Buy

NUKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.07 Buy
20-day SMA: 9 Buy
50-day SMA: 4.99 Buy
200-day SMA: 4.78 Buy
8-day EMA: 26.51 Buy
20-day EMA: 14.21 Buy
50-day EMA: 7.47 Buy
200-day EMA: 11.77 Buy

Protara Therapeutics Earnings Growth & TARA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and a decrease next year of $0.05 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Protara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):